|
|
 |
| A wide range of applications |
 |
|
| Miltenyi Bioprocess, the contract manufacturing division of Miltenyi Biotec, provides in-depth knowledge and state-of-the-art facilities for development and production of medical devices and reagents for the aseptic separation of specific human cells. This separation technology is based on monoclonal antibodies and alternative ligands, both directed to different cell surface markers or other specific targets, covalently immobilized to biodegradable super-paramagnetic beads or non-biodegradable beads. With the development, production, and registration of numerous CliniMACS® Reagents, Miltenyi Bioprocess has established a generic reagent development and production process. This process will significantly reduce the “time-to-market” for your cell therapy application. |
|
|
|
|
|
| My favorites |
| Your current favorite list is empty. |
|
|
|
© 1999 - 2010 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|
